The U.S. peptide therapeutics market had an estimated valuation of $21 billion in 2025, and is projected to grow to nearly $35 billion by 2035 (1). Injectable peptides are currently the most dominant ...
Lupin announced that its subsidiary, Lupin Manufacturing Solutions (LMS), a global CRDMO, is undertaking a strategic expansion of its Dabhasa manufacturing facility.
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Amide Technologies, a biotech that synthesizes challenging peptides, announced today that it has begun commercializing its novel peptide manufacturing platform. The ...
RANCHO CORDOVA, Calif., March 19, 2026 (GLOBE NEWSWIRE) -- SK pharmteco today announced a significant funding commitment to support strategic initiatives within its viral vector business, while ...
Lupin Manufacturing Solutions expands Dabhasa manufacturing facility: Our Bureau, Mumbai Thursday, March 19, 2026, 13:30 Hrs [IST] Lupin Manufacturing Solutions (LMS), a global CR ...
The CDMO’s Module 1 commercial production facility to be operational by summer 2026 Hyderabad, March 9th 2026: Neuland Laboratories will open its new commercial peptide facility in the summer of 2026 ...
This collaboration aims to enhance supply chain resilience, improve operational efficiency and accelerate readiness for the rapidly expanding global peptides market. This partnership strengthens LMS ...
BOSTON--(BUSINESS WIRE)--Mytide Therapeutics, a company transforming peptide manufacturing with predictive analytics and machine learning, has raised $7 million in Series A financing. The round was ...
Hosted on MSN
Weight-loss drugs are creating an environmental disaster—a new water-based method aims to change that
The world is in the middle of a peptide drug revolution. These short chains of amino acids—the building blocks of proteins—sit at the heart of some of the most successful medicines ever created, from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results